IPSC - Century Therapeutics GAAP EPS of -$0.53 beats by $0.06 revenue of $2.22M beats by $0.98M November, 10 2022 09:19 AM Century Therapeutics Inc. Century Therapeutics press release ( NASDAQ: IPSC ): Q3 GAAP EPS of -$0.53 beats by $0.06 . Revenue of $2.22M beats by $0.98M . For further details see: Century Therapeutics GAAP EPS of -$0.53 beats by $0.06, revenue of $2.22M beats by $0.98M